Jason earned an MBA at the Schulich School of Business, York University, Canada specializing in international business & marketing. His undergraduate work was completed at McMaster University in Hamilton, Ontario, where he earned an economics degree.
Jason has negotiated and facilitated numerous investment and partnership agreements with large multi-national corporations.
Jason has been involved with many technology companies working on operations, business development and marketing strategies.
He is also a former professional football player, seasoned investor and has built several successful businesses.
Winson Li is a former Private Equity Analyst with experience in valuation analysis, in-depth market research and company due diligence.
Winson has been a consultant for business development, marketing and third party negotiation strategies for start-ups and mature businesses in technology and e-Commerce.
Winson holds an Honours in Business Administrative Studies, specialized in Finance, from York University.
Yan is a researcher and entrepreneur at heart, who is trained in mechanical engineering and biophysics. He brings experience from the private start-up world, developing and managing multiphase projects, creating intellectual property and know-how. Currently, Yan dedicates his time and knowledge to growing passionate teams to bring meaningful technologies to the market.
Mr. Park is a certified hedge fund professional (CHP), with additional CHP certifications at the highest level in portfolio analytics and risk management. He also attended the Notre Dame Mendoza college of business (leadership and management) and has served in executive leadership positions for over 20 years.
Mr Park has closed several acquisitions and multi million-dollar lines of credit from hedge funds, as well as negotiated and or closed many mergers, strategic partnerships, license and or sponsored research agreements and joint ventures.
As an experience practitioner of business strategy, he has read, studied and applied numerous books and countless articles relating to business strategy (according to the wall street journal, the most sought after executive skill set is strategic thinking).
As President of Techenterprises, LLC, I have over 25 years of management and consulting experience in the food, nutrition and pharmaceutical industries, and have served as a Regulatory Officer, or managed regulatory activities for a number of biotech companies. I have personally submitted, or actively participated in the filing of more than ten INDs, and have never had one rejected by the FDA. I am presently managing the IND files for several pharmaceutical companies, and am presently managing two Phase II clinical trial programs. For my medical device clients, I have conducted clinical research and have written 510(k) applications. In the nutritional and food areas, I have written twelve GRAS Notifications and a New Dietary Ingredient Dossier. All documents that were written and submitted to the FDA were accepted.
In addition to my activities with Techenterprises, LLC, I have provided services as a Principal in ABIC International Consultants, and as an Associate of other consulting companies. During these years I have additionally contributed business development, marketing strategy, licensing and acquisition support, new product development and clinical and regulatory services to domestic and foreign multinational companies, as well as start-up ventures. I was recruited to assume interim-CEO positions at Nextech Healthcare (nutrition and biotech), EmphyCorp, Inc (respiratory therapy) and the Avicena Group (nutrition and pharmaceuticals). I am a co-founder of three pharmaceutical companies and two other technical-based companies.
My prior management positions within the pharmaceutical industry, which included drug, device, and clinical nutrition regulatory and clinical management, include that of Department Head of Nutritional Sciences for Syntex Laboratories and Director of Clinical and Pharmaceutical Research for McGaw Laboratories (division of American Hospital Supply Corp). In these positions I was responsible for all new drug and nutritional research and product development, and the preparation of regulatory documents, including INDs. At McGaw I was also a member of the international licensing and acquisitions group.
I received my MS degree in Food Science and my doctoral degree in nutritional physiology from Rutgers University, and did graduate work in business administration at Santa Clara University. I hold several patents and have a number of publications in the pharmaceutical, nutrition, and food fields. On occasion I teach graduate level courses at Chapman University where I am an Adjunct Professor.
Dr. John Finley’s combination of academic, industrial, and government experience in the areas of nutritional food ingredients and consumer product formulations are widely recognized. Expertise includes foods than enhance health and wellness. Dr. Finley’s research interests include low calorie ingredients, anti-inflammatory compounds in the diet and modified lipids.
At Kraft Foods Dr. Finley was in the long-range research and development area where he developed several low-calorie technologies and satiety enhancing products. Dr. Finley also served as the internal biotechnology consultant, dealing with use of biotech crops as well as marketing and regulatory issues.
At Monsanto he was the leader of the food science program which was focused on delivery of intense sweeteners and reduced calorie ingredient development. One of his major roles was in the due diligence for acquisitions
At Nabisco Dr Finley assembled and led the Fundamental Science program which resulted in multiple innovations and technologies to support the Nabisco businesses. In that role he assembled a group of 50 scientists and engineers which for 10 years were at the forefront of food research. Results were cost savings of tens of millions of dollars per year, development and leadership of low calorie fat technology.
Dr Finley has authored over 100 technical publications, edited eleven books and holds over 50 patents. Currently he is an associate editor for the Journal of Agricultural and Food Chemistry. Dr. Finley holds a B.S. Degree in Chemistry from LeMoyne College and a Ph.D. in Biochemistry and Food Science from Cornell University.
Candida Rebello is a postdoctoral researcher at the Pennington Biomedical Research Center and is supported by a National Institutes of Health (NIH) T-32 Postdoctoral Fellowship.
Dr. Rebello holds a Bachelor of Law degree (LL.B.) from the University of Mumbai, India. Subsequently, she earned the Master of Science and Doctoral degrees in Nutrition from Louisiana State University, Baton Rouge.
Dr. Rebello is researching the effects of bioactive components from food on the metabolic syndrome in primary human adipocytes, as a prelude to her goal of engaging in translational science where the results obtained from laboratory intervention studies are evaluated in human subjects.
Dr. Rebello is a registered dietitian and has worked as a research dietitian assisting with food development and the conduct of clinical trials at the Pennington Biomedical Research Center.
Dr. Rebello also serves as a principal and co-investigator on clinical trials and has 20 publications in peer-reviewed journals. Dr. Rebello is a member of professional societies such as the American Society for Nutrition, the Academy of Nutrition and Dietetics, and is a Fellow of the Obesity Society.
Dr. Gettys, a nutritional biochemist and physiologist by training, has a broad interest in understanding how organisms respond to changes in dietary composition in real time and engage the appropriate homeostatic responses.
Although it has long been axiomatic that dietary composition has a deterministic role in overall health, Dr. Gettys’ studies have begun to identify the signaling systems that match the specific homeostatic response to the specific change in dietary composition.
His work has established that essential amino acids are the components of dietary protein that are being sensed, and that limiting the dietary content of specific essential amino acids produces a highly beneficial series of physiological responses.
His work is central to an emerging consensus that essential amino acid nutrition provides critical regulatory input to the control of energy balance and the coordination of lipid and carbohydrate metabolism in peripheral tissues.
The goal of Dr. Gettys’ work is to translate this knowledge of essential amino acid nutrition into therapeutic diets that limit weight gain, maintain insulin sensitivity, and prevent the development of metabolic disease.
Frank Greenway, M.D. is a professor and director for the Outpatient Research Unit at Pennington Biomedical Research Center in Baton Rouge.
He graduated from Stanford University, obtained his medical degree from the UCLA, did his internal medicine and endocrinology training at Harbor-UCLA and has boards in internal medicine and endocrinology.
Dr. Greenway practiced internal medicine, endocrinology and taught at Harbor-UCLA for 20 years before coming to the Pennington as a Professor. His interest is in developing new treatments for obesity including drugs, dietary herbal supplements, medical foods and devices. His laboratory focuses on identifying food plants that have the potential to aid in weight loss.
Dr. Greenway serves as the principal investigator on numerous clinical trials with sponsorship by NIH and industry, is a member of a number of professional societies including the American College of Physicians (fellow), The Obesity Society (fellow), the American Society for Nutrition, the American Diabetes Association and the Endocrine Society. Dr. Greenway has published more than 200 articles, and holds several patents.
Phil Roberts, MD MS ABAARM has over thirty years of combined training and clinical experience in general surgery, emergency medicine and functional medicine. Having sought out additional medical training due to his own health issues, he became quite interested in seeking disease reversal through nutrients and bio-identical hormones.
He obtained a masters in metabolic and nutritional medicine while becoming an advanced diplomat with the academy of anti-ageing functional and regenerative medicine.
This allowed him to witness the power of these therapies in reversing many chronic diseases.
He served on the sci-med board of a leading nutritional company in the US for several years.
Extremely honoured, he is, to be involved with this world class team seeking to reverse obesity, diabetes and fatty liver disease in animals and humans.